DEF 14A: Myomo, Inc. Announces 2024 Annual Meeting of Stockholders

Myomo, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 5, 2024, to elect directors and ratify the appointment of its independent auditor.

Summary

• Myomo, Inc. will hold its 2024 Annual Meeting of Stockholders on June 5, 2024, at 9:00 a.m. Eastern Time, in a virtual format.
• Stockholders of record as of April 10, 2024, are entitled to vote at the meeting.
• The meeting will include the election of two Class I directors (Thomas A. Crowley and Milton M. Morris) for a three-year term ending at the 2027 annual meeting.
• Stockholders will also vote to ratify the appointment of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• The Board of Directors recommends voting FOR the election of the director nominees and FOR the ratification of Marcum LLP's appointment.
• Proxy materials are available online at www.proxydocs.com/MYO.
• Stockholders must register by May 31, 2024, at 5:00 p.m. Eastern Time to attend the virtual meeting.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The positive aspects include the company's commitment to good corporate governance and providing stockholders with multiple voting options. The sentiment is slightly positive due to the routine nature of the meeting and the board's recommendations.

Positives

• The company is providing access to proxy materials online, reducing environmental impact and costs.
• Stockholders have multiple options for voting: online, by telephone, or by mail.
• The board of directors has a majority of independent directors.
• The company has a Code of Business Conduct and Ethics in place.
• The company has a policy for pre-approval of audit and non-audit services by the audit committee.

Risks

• The document mentions risks related to the company's financial condition, development, commercialization activities, operations, strategic direction, and intellectual property, as discussed in the Annual Report on Form 10-K.
• The insider trading policy expressly prohibits short sales and, without prior approval, derivative transactions of our stock by our executive officers, directors and specified other employees and their respective affiliates, purchases or sales of puts, calls or other derivative securities of the company or any derivative securities that provide the economic equivalent of ownership of any of our securities or an opportunity, direct or indirect, to profit from any change in the value of our securities, or other hedging transactions.

Future Outlook

The board of directors knows of no other matters that will be presented for consideration at the Annual Meeting.

Management Comments

• Paul R. Gudonis, President and Chief Executive Officer, expresses pleasure in inviting stockholders to the Annual Meeting and emphasizes the importance of their vote.

Industry Context

The document does not explicitly discuss broader industry trends, but the use of a virtual meeting format reflects a growing trend in corporate governance to enhance accessibility and reduce costs.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards.
• However, the company's corporate governance practices, such as having a majority of independent directors and an audit committee, are consistent with standard practices for publicly traded companies in the United States.
• The executive compensation arrangements are also typical, with a mix of base salary, annual bonuses, and long-term equity incentives.

Related Party Transactions

• In January 2024 Myomo entered into a securities purchase agreement with certain investors pursuant to which they sold, in a registered direct offering, an aggregate of 1,354,218 shares of their common stock at a purchase price of $3.80 per share and pre-funded warrants to purchase 224,730 shares of common stock at a purchase price of $3.7999 per pre-funded warrant.
• In August 2023 Myomo sold, in a registered public offering, an aggregate of 5,413,334 shares of their common stock at a purchase price of $0.60 per share and pre-funded warrants to purchase 1,920,000 shares of common stock at a purchase price of $0.5999 per pre-funded warrant.
• In January 2023 Myomo entered into a securities purchase agreement with certain investors pursuant to which they sold, in a registered public offering, an aggregate of 13,169,074 shares of their common stock at a purchase price of $0.325 per share and pre-funded warrants to purchase 6,830,926 shares of common stock at a purchase price of $0.3249 per pre-funded warrant.

Stakeholder Impact

• Shareholders are asked to vote on key proposals, influencing the company's direction.
• The outcome of the votes will affect the composition of the board and the selection of the company's auditor.
• Executive compensation decisions impact the alignment of management's interests with those of shareholders.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• Stockholders who wish to attend the virtual Annual Meeting must register by May 31, 2024.
• The company will announce preliminary voting results at the Annual Meeting and report final results in a Form 8-K filing.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Directors, Stockholders, Voting, Marcum LLP, Audit Committee, Corporate Governance, Executive Compensation, Myomo